Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
C4 Therapeutics, Inc.
IPO Date: October 2, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $149.82M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.50 | 3.92%
Avg Daily Range (30 D): $0.10 | 5.66%
Avg Daily Range (90 D): $0.09 | 5.31%
Institutional Daily Volume
Avg Daily Volume: 1.34M
Avg Daily Volume (30 D): 1.29M
Avg Daily Volume (90 D): 1.04M
Trade Size
Avg Trade Size (Sh.): 137
Avg Trade Size (Sh.) (30 D): 174
Avg Trade Size (Sh.) (90 D): 169
Institutional Trades
Total Inst.Trades: 1,040
Avg Inst. Trade: $1.93M
Avg Inst. Trade (30 D): $1.85M
Avg Inst. Trade (90 D): $1.51M
Avg Inst. Trade Volume: .2M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.19M
Avg Closing Trade (30 D): $7.13M
Avg Closing Trade (90 D): $2.32M
Avg Closing Volume: 186.32K
   
News
May 7, 2025 @ 11:00 AM
C4 Therapeutics Reports First Quarter 2025 Financi...
Source: C4 Therapeutics
Jan 29, 2025 @ 6:00 PM
BRAF Inhibitors Market to Register Incremental Gro...
Source: Delveinsight
Jan 9, 2025 @ 3:53 PM
NUT Midline Carcinoma Treatment Market Research Re...
Source: Researchandmarkets.Com
Dec 8, 2024 @ 5:30 PM
C4 Therapeutics Presents Cemsidomide Phase 1 Data ...
Source: N/A
Nov 20, 2024 @ 12:00 PM
C4 Therapeutics Appoints Accomplished Oncology Exe...
Source: N/A
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-.37 $-.35
Diluted EPS $-.37 $-.35
Revenue $ $ 7.24M $ 15.36M
Gross Profit $ $ $
Net Income / Loss $ $ -26.32M $ -24.67M
Operating Income / Loss $ $ -29.16M $ -28.24M
Cost of Revenue $ $ $
Net Cash Flow $ $ -4.21M $ -13.47M
PE Ratio